SPALLONE, VINCENZA
 Distribuzione geografica
Continente #
NA - Nord America 42.206
EU - Europa 5.273
AS - Asia 4.036
SA - Sud America 681
Continente sconosciuto - Info sul continente non disponibili 490
AF - Africa 88
OC - Oceania 86
Totale 52.860
Nazione #
US - Stati Uniti d'America 41.870
IT - Italia 1.968
SG - Singapore 1.664
CN - Cina 740
UA - Ucraina 559
DE - Germania 538
BR - Brasile 498
FR - Francia 418
RU - Federazione Russa 381
IE - Irlanda 352
VN - Vietnam 336
HK - Hong Kong 305
KR - Corea 257
GB - Regno Unito 239
PL - Polonia 176
FI - Finlandia 168
BD - Bangladesh 162
CA - Canada 141
SE - Svezia 136
MX - Messico 130
JP - Giappone 114
NL - Olanda 99
IN - India 92
ES - Italia 78
AU - Australia 70
ID - Indonesia 56
TR - Turchia 51
AR - Argentina 42
CO - Colombia 37
TH - Thailandia 36
ZA - Sudafrica 33
IQ - Iraq 30
PH - Filippine 28
MY - Malesia 27
CL - Cile 26
CH - Svizzera 25
KG - Kirghizistan 24
PE - Perù 24
EC - Ecuador 23
BE - Belgio 20
PK - Pakistan 20
AT - Austria 17
EG - Egitto 16
IR - Iran 16
NZ - Nuova Zelanda 15
UZ - Uzbekistan 15
CR - Costa Rica 14
HU - Ungheria 14
DK - Danimarca 12
EU - Europa 12
RO - Romania 12
CZ - Repubblica Ceca 10
BG - Bulgaria 9
GR - Grecia 9
JM - Giamaica 9
PY - Paraguay 9
VE - Venezuela 9
MA - Marocco 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
GT - Guatemala 7
IL - Israele 7
LT - Lituania 7
JO - Giordania 6
KE - Kenya 6
SA - Arabia Saudita 6
UY - Uruguay 6
AZ - Azerbaigian 5
BB - Barbados 5
DZ - Algeria 5
NI - Nicaragua 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
HN - Honduras 4
MN - Mongolia 4
NP - Nepal 4
PR - Porto Rico 4
AM - Armenia 3
GE - Georgia 3
MD - Moldavia 3
PT - Portogallo 3
SV - El Salvador 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BZ - Belize 2
CG - Congo 2
CM - Camerun 2
EE - Estonia 2
HR - Croazia 2
ME - Montenegro 2
NG - Nigeria 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
Totale 52.370
Città #
Wilmington 11.065
Woodbridge 10.991
Houston 10.007
Singapore 997
Fairfield 804
Chandler 725
Ashburn 659
Ann Arbor 586
San Jose 468
Jacksonville 412
Dublin 330
Hong Kong 294
Beijing 293
Seattle 286
Cambridge 265
Medford 247
Rome 247
Council Bluffs 241
New York 219
Dearborn 215
Kraków 153
Los Angeles 149
Santa Clara 147
The Dalles 144
Lawrence 117
Milan 117
Ho Chi Minh City 110
Redwood City 104
Dallas 90
Tokyo 86
Menlo Park 80
Lauterbourg 78
Buffalo 75
Hanoi 70
Helsinki 68
San Diego 52
Atlanta 48
Moscow 45
Florence 44
São Paulo 44
Bologna 41
London 38
Mülheim 38
Jakarta 36
Phoenix 36
Boardman 35
Naples 35
Falls Church 34
Toronto 34
Mountain View 33
Orem 31
Bangkok 28
Nuremberg 28
Zhengzhou 28
Redondo Beach 27
Palo Alto 26
Brooklyn 25
Chicago 25
Montreal 25
Sydney 25
Bari 24
Columbus 24
Denver 24
Palermo 24
Verona 24
University Park 23
Boston 22
Munich 22
Santiago 22
Da Nang 21
Detroit 21
Lima 21
Newark 21
Ankara 20
Dong Ket 20
Guangzhou 20
Kansas City 20
Barcelona 19
Kunming 19
Nanjing 19
Frankfurt am Main 18
Philadelphia 18
Shanghai 18
Padova 17
Turin 17
Warsaw 17
Brussels 16
Calgary 16
Genoa 16
Modena 16
Norwalk 16
Brasília 15
Miami 15
Mumbai 15
Trieste 15
Washington 15
Amsterdam 14
Madrid 14
Bogotá 13
Budapest 13
Totale 42.544
Nome #
Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes 1.365
Position Statement sull’appropriatezza nella prescrizione degli esami di laboratorio in diabetologia 987
Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation 972
Neuropatia Diabetica 666
Determinants of Orthostatic Hypotension in Type 2 Diabetes: Is Cardiac Autonomic Neuropathy the Main Factor? 613
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 578
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 555
Raccomandazioni sull’uso dei test cardiovascolari nella diagnosi di neuropatia autonomica diabetica 538
Diagnostic value of different autonomic symptoms assessed by COMPASS 31 for cardiovascular autonomic neuropathy and diabetic polyneuropathy 537
Il trattamento della psoriasi nell’adulto. Linea guida 25. 533
Neuropatia Diabetica 529
Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction? 520
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 518
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 510
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 510
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 505
Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients? 498
Neuropatia diabetica autonomica, pressione arteriosa e funzione renale (Valsalva Lecture) 494
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 494
Combination Therapy in Diabetic Neuropathy 494
Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic 491
Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. 486
Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes 485
Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy 485
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy 482
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 482
1965-2015, 1991-2015. 50 years of the EASD, 25 years of Neurodiab. Enduring friendship. A legacy for the future 477
Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics 474
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 473
Diagnosis of cardiovascular autonomic neuropathy in diabetes 472
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 472
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 471
Effects of somatostatin on established induced ketosis 469
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 469
Change in glucose metabolism after long-term treatment with deflazacort and betamethasone 467
Neuropatia e assistenza al diabetico 467
GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). 458
Benfotiamine: Commentary and update on recent studies 458
Twenty-four-hour pattern of blood pressure and spectral analysis of heart rate variability in diabetic patients with various degrees of autonomic neuropathy. Comparison to standard cardiovascular tests. 457
Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes 456
Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy 455
Autonomic neuropathy: Clinical and instrumental findings 452
Carbohydrate metabolism in hypertension: influence of treatment 452
Neuropatia diabetica in Italia 450
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy 450
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 450
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 447
Neuropathy in chronic kidney disease 447
Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. 445
Psychopathology and dietary restriction: A comparison between eating disorders and Type 1 diabetes 443
Autonomic neuropathy and secondary hyperparathyroidism in uraemia 439
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 435
The relationship of autonomic neuropathy to other diabetic complications 435
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 434
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 433
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 433
Methods of investigation for cardiac autonomic dysfunction in human research studies 431
Prevenzione degli eventi avversi correlati alla presenza di complicanze del diabete (ipotensione ortostatica, danno renale acuto da mezzo di contrasto e ulcere da pressione) 430
Perspectives in Diabetic Neuropathy: Update on Diagnostic Criteria and Treatment Options 430
Study of conduction velocity in diabetic with autonomic neuropathy. 427
Management of painful diabetic neuropathy: guideline guidance or jungle? 427
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 427
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 426
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 425
MicroRNA genetic variations: association with type 2 diabetes 424
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 423
Might genetics play a role in understanding and treating diabetic polyneuropathy? 422
Efficacy and safety of lacosamide in painful diabetic neuropathy 421
Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus 418
Why not to use the handgrip test in the assessment of cardiovascular autonomic neuropathy among patients with diabetes mellitus? 416
Diabetic autonomic neuropathy 415
Painful and painless diabetic neuropathy: one disease or two? 415
Should we avoid the handgrip test in the assessment of cardiovascular autonomic neuropathy in diabetic patients? Exploratory factor analysis 412
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 408
Improvement in peripheral and autonomic neuropathy during 18 months of treatment with subcutaneous continuous insulin infusion in type 1 diabetics 407
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 406
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 402
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 401
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 401
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 396
Il corretto iter diagnostico della Neuropatia Diabetica 395
Costruire l'identità del nutrizionista 394
Le nuove frontiere della nutrizione. 393
Relationship between hyperfunction of antral G cells (AGCH) and autonomic neuropathy (AN) in diabetic patients 393
Reappraisal of the diagnostic role of orthostatic hypotension in diabetes 389
Painful Diabetic Polyneuropathy: Approach to Diagnosis and Management 386
Reply to Circulating erythropoietin in diabetes mellitus. 385
Time for a Consensus Conference on pain in neurorehabilitation. 382
Comparative study of periferal and autonomic neuropathy in diabetes 381
Novità in Endocrinologia. Calcificazione vascolare e osteolisi nella neuropatia diabetica - il legame mancante è il RANK-L? 380
Screening e trattamento della neuropatia diabetica 380
Terapia farmacologica della neuropatia diabetica dolorosa 371
Blood Pressure Variability and Autonomic Dysfunction 371
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 368
Microvascular complications in children and adolescents with type 1 diabetes 368
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 365
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes 365
Disfunzione autonomica gastro-enterica e genito-urinaria 361
Impaired alpha cell function in conditions with cortisol deficiency 361
Glycaemic control and gastric emptying 359
Totale 46.524
Categoria #
all - tutte 108.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.391


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.330 0 178 76 95 87 168 60 68 73 93 90 342
2022/20232.062 195 131 103 235 182 410 174 145 197 55 141 94
2023/20241.016 100 54 72 78 105 175 49 69 55 75 69 115
2024/20252.896 135 664 304 202 136 146 257 145 374 211 213 109
2025/20265.525 297 194 516 460 488 200 695 508 617 435 837 278
2026/20271.106 737 369 0 0 0 0 0 0 0 0 0 0
Totale 52.860